Found: 64
Select item for more details and to access through your institution.
Refractory immune-mediated and haematological diseases: candidates for peptide receptor radiotherapy?
- Published in:
- European Journal of Endocrinology, 2000, p. S53, doi. 10.1530/eje.0.143s053
- By:
- Publication type:
- Article
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues.
- Published in:
- Neuroendocrinology, 2017, v. 105, n. 3, p. 295, doi. 10.1159/000475526
- By:
- Publication type:
- Article
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging.
- Published in:
- Neuroendocrinology, 2017, v. 105, n. 3, p. 212, doi. 10.1159/000471879
- By:
- Publication type:
- Article
Is There an Additional Value of Using Somatostatin Receptor Subtype 2a Immunohistochemistry Compared to Somatostatin Receptor Scintigraphy Uptake in Predicting Gastroenteropancreatic Neuroendocrine Tumor Response?
- Published in:
- Neuroendocrinology, 2016, v. 103, n. 5, p. 560, doi. 10.1159/000441604
- By:
- Publication type:
- Article
Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy.
- Published in:
- Neuroendocrinology, 2013, v. 97, n. 1, p. 74, doi. 10.1159/000335018
- By:
- Publication type:
- Article
ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms.
- Published in:
- Neuroendocrinology, 2012, v. 95, n. 2, p. 74, doi. 10.1159/000335595
- By:
- Publication type:
- Article
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogs.
- Published in:
- Neuroendocrinology, 2009, v. 90, n. 2, p. 220, doi. 10.1159/000225951
- By:
- Publication type:
- Article
ENETS Consensus Guidelines for the Management of Peritoneal Carcinomatosis from Neuroendocrine Tumors.
- Published in:
- Neuroendocrinology, 2010, v. 91, n. 4, p. 333, doi. 10.1159/000286700
- By:
- Publication type:
- Article
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Somatostatin Receptor Imaging with In-Pentetreotide.
- Published in:
- Neuroendocrinology, 2009, v. 90, n. 2, p. 184, doi. 10.1159/000225946
- By:
- Publication type:
- Article
Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy.
- Published in:
- International Journal of Cancer, 1999, v. 81, n. 4, p. 658, doi. 10.1002/(SICI)1097-0215(19990517)81:4<658::AID-IJC24>3.0.CO;2-P
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours.
- Published in:
- Acta Oncologica, 2007, v. 46, n. 6, p. 723, doi. 10.1080/02841860701441848
- By:
- Publication type:
- Article
Parathyroid Hormone-Related Peptide (PTHrP) Secretion by Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): Clinical Features, Diagnosis, Management, and Follow-Up.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
[<sup>123</sup>I]Metaiodobenzylguanidine and [<sup>111</sup>In]Octreotide Uptake in Benign and Malignant Pheochromocytomas.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2001, v. 86, n. 2, p. 685, doi. 10.1210/jc.86.2.685
- By:
- Publication type:
- Article
Chromogranin A as Serum Marker for Neuroendocrine Neoplasia: Comparison with Neuron-Specific Enolase and the α-Subunit of Glycoprotein Hormones.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1997, v. 82, n. 8, p. 2622, doi. 10.1210/jc.82.8.2622
- By:
- Publication type:
- Article
High Serum Levels of the Thyrotropin-Releasing Hormone-Like Peptide Pyroglutamyl-Glutamyl-Prolineamide in Patients with Carcinoid Tumors.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 1996, v. 81, n. 8, p. 2816, doi. 10.1210/jc.81.8.2816
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy.
- Published in:
- Annals of the New York Academy of Sciences, 2004, v. 1014, n. 1, p. 234, doi. 10.1196/annals.1294.026
- By:
- Publication type:
- Article
Somatostatin receptor imaging for neuroendocrine tumors.
- Published in:
- Pituitary, 2006, v. 9, n. 3, p. 243, doi. 10.1007/s11102-006-0270-5
- By:
- Publication type:
- Article
Radionuclide therapy in neuroendocrine tumors.
- Published in:
- European Journal of Endocrinology, 2015, v. 172, n. 1, p. R1, doi. 10.1530/EJE-14-0488
- By:
- Publication type:
- Article
Nephrotoxicity after PRRT with Lu-DOTA-octreotate.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 10, p. 1802, doi. 10.1007/s00259-016-3382-9
- By:
- Publication type:
- Article
Subacute haematotoxicity after PRRT with Lu-DOTA-octreotate: prognostic factors, incidence and course.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 3, p. 453, doi. 10.1007/s00259-015-3193-4
- By:
- Publication type:
- Article
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 1, p. 5, doi. 10.1007/s00259-014-2893-5
- By:
- Publication type:
- Article
Hypocalcaemia after treatment with [Lu-DOTA,Tyr]octreotate.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2013, v. 40, n. 12, p. 1843, doi. 10.1007/s00259-013-2503-y
- By:
- Publication type:
- Article
Effects of therapy with [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]octreotate on endocrine function.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 11, p. 1758, doi. 10.1007/s00259-009-1151-8
- By:
- Publication type:
- Article
Bone marrow dosimetry in peptide receptor radionuclide therapy with [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]octreotate.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 7, p. 1138, doi. 10.1007/s00259-009-1072-6
- By:
- Publication type:
- Article
Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [Lu-DOTA,Tyr]octreotate.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2008, v. 35, n. 4, p. 749, doi. 10.1007/s00259-007-0691-z
- By:
- Publication type:
- Article
Report on short-term side effects of treatments with Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2008, v. 35, n. 4, p. 743, doi. 10.1007/s00259-007-0688-7
- By:
- Publication type:
- Article
Peptide receptor radionuclide therapy with <sup>177</sup>Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2007, v. 34, n. 8, p. 1219, doi. 10.1007/s00259-006-0355-4
- By:
- Publication type:
- Article
Radiolabelled peptides for tumour therapy: current status and future directions: Plenary lecture at the EANM 2002.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 3, p. 463, doi. 10.1007/s00259-002-1107-8
- By:
- Publication type:
- Article
Pre-clinical evaluation of [.
- Published in:
- International Journal of Cancer, 1999, v. 83, n. 5, p. 657, doi. 10.1002/(SICI)1097-0215(19991126)83:5<657::AID-IJC15>3.0.CO;2-Y
- By:
- Publication type:
- Article
Somatostatin Receptor 2–Targeting Compounds.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, p. 54S, doi. 10.2967/jnumed.117.191015
- By:
- Publication type:
- Article
Perspective on <sup>177</sup>Lu-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 7, p. 1002, doi. 10.2967/jnumed.115.171363
- By:
- Publication type:
- Article
Radiopeptides for Imaging and Therapy: A Radiant Future.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 12, p. 1809, doi. 10.2967/jnumed.115.161158
- By:
- Publication type:
- Article
Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr³]Octreotate.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 11, p. 1647, doi. 10.2967/jnumed.115.158899
- By:
- Publication type:
- Article
Comparison of Response Evaluation in Patients with Gastroenteropancreatic and Thoracic Neuroendocrine Tumors After Treatment with [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr³]Octreotate.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 10, p. 1689, doi. 10.2967/jnumed.112.117408
- By:
- Publication type:
- Article
Tumor Response Assessment to Treatment with [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr³]Octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors: Differential Response of Bone Versus Soft-Tissue Lesions.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 9, p. 1359, doi. 10.2967/jnumed.112.102871
- By:
- Publication type:
- Article
Quality of Life in 265 Patients with Gastroenteropancreatic or Bronchial Neuroendocrine Tumors Treated with [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr³]Octreotate.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 9, p. 1361, doi. 10.2967/jnumed.111.087932
- By:
- Publication type:
- Article
Salvage Therapy with <sup>177</sup>Lu-Octreotate in Patients with Bronchial and Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 3, p. 383, doi. 10.2967/jnumed.109.068957
- By:
- Publication type:
- Article
Efficacy of Adalimumab in Chronically Active and Symptomatic Patients with Sarcoidosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2011, v. 184, n. 10, p. 1214, doi. 10.1164/ajrccm.184.10.1214
- By:
- Publication type:
- Article
Additional hepatic <sup>166</sup>Ho-radioembolization in patients with neuroendocrine tumours treated with <sup>177</sup>Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Somatostatin receptor scintigraphy in sarcoidosis.
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Myocardial metastases from neuroendocrine tumors: incidence and relevance.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Consensus Guidelines for the Management of Patients with Liver Metastases from Digestive (Neuro)endocrine Tumors: Foregut, Midgut, Hindgut, and Unknown Primary.
- Published in:
- Neuroendocrinology, 2008, v. 87, n. 1, p. 47, doi. 10.1159/000111037
- By:
- Publication type:
- Article
Poorly Differentiated Carcinomas of the Foregut (Gastric, Duodenal and Pancreatic).
- Published in:
- Neuroendocrinology, 2006, v. 84, n. 3, p. 212, doi. 10.1159/000098013
- By:
- Publication type:
- Article
Well-Differentiated Gastric Tumors/Carcinomas.
- Published in:
- Neuroendocrinology, 2006, v. 84, n. 3, p. 158, doi. 10.1159/000098007
- By:
- Publication type:
- Article
Well-Differentiated Duodenal Tumor/Carcinoma (Excluding Gastrinomas).
- Published in:
- Neuroendocrinology, 2006, v. 84, n. 3, p. 165, doi. 10.1159/000098008
- By:
- Publication type:
- Article
Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma.
- Published in:
- Neuroendocrinology, 2006, v. 84, n. 3, p. 183, doi. 10.1159/000098010
- By:
- Publication type:
- Article
Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma.
- Published in:
- Neuroendocrinology, 2006, v. 84, n. 3, p. 196, doi. 10.1159/000098012
- By:
- Publication type:
- Article
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 4, p. 895, doi. 10.1007/s00259-019-04601-3
- By:
- Publication type:
- Article
PRRT genomic signature in blood for prediction of <sup>177</sup>Lu-octreotate efficacy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 7, p. 1155, doi. 10.1007/s00259-018-3967-6
- By:
- Publication type:
- Article
The Role of Somatostatin Receptor Scintigraphy in Gastroenteropancreatic Endocrine Tumors.
- Published in:
- Digestive Surgery, 1994, v. 11, n. 3-6, p. 456, doi. 10.1159/000172302
- By:
- Publication type:
- Article